Background: Accurate self-monitoring of blood glucose (SMBG) is a key component of effective self-management of glycemic control.
Methods: The OneTouch Verio Reflect and OneTouch Ultra Plus Reflect BG monitoring systems were evaluated for accuracy in a clinical setting. Subjects also used the meters for a one-week trial period and reported their level of satisfaction with meter features.
Results: Both systems were accurate over a wide glucose range and met lay user and system accuracy BG standards described in ISO15197:2015. Subjects felt that the features of a meter with a dynamic color range indicator and personalized guidance, insight, and encouragement could provide significant benefits to them in the management of their diabetes.
Conclusions: Both meter systems were accurate over a wide glucose range and the features of the meter and messages were well received by patients in a short take-home trial.
Clinical Trial Registration: Clinicaltrials.gov NCT0351542.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7196872 | PMC |
http://dx.doi.org/10.1177/1932296819867396 | DOI Listing |
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!